Coming off Imatinib – Nic Puntis
Imatinib - a Targeted Therapy Drug used to Treat Cancer | FAQ English | Onco Cancer CareПодробнее
Taking Imatinib Gleevec for CML LeukemiaПодробнее
What is Imatinib?Подробнее
What do you need to know about Imatinib® (Generic Gleevec)?Подробнее
Serum Imatinib (Gleevec) Levels Predict GIST ResponseПодробнее
Dr. Pamela Crilley on Imatinib and Second Generation TKIsПодробнее
The current standard of care in CML and insights into the use of first- and second-generation TKIsПодробнее
Imatinib tablets for Chronic myeloid leukemiaПодробнее
Gleevec mechanism of actionПодробнее
Гливек при опухолях, Механизм действия ГливекПодробнее
IMATINIB (Gleevec) Mechanism of action. Side effects:Pathogenesis of Periorbital edema Muscle CrampsПодробнее
Thromboembolic event rates in patients with PV: a real-world analysisПодробнее
Medical Management After CLTIALI Diagnosis E A Secemsky PAD SessionПодробнее
The importance of better selecting patients with CML who are eligible for treatment discontinuationПодробнее
Starting first-line treatment, update on Imatinib.Подробнее
Gleevec | MOA AnimationПодробнее
No Differences in Molecular Relapse-Free Survival After Stopping Imatinib TreatmentПодробнее
